Immuneering Corporation - Class A —— 季度财务数据 (NASDAQ:IMRX) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -14.51 M-14.08 M-9.45 M-11.98 M-9.84 M -45.34 M 投资活动产生的现金 5.49 M-8 945-2 116-7 255-88.72 M -88.74 M 融资活动产生的现金 -40.99 K13.81 M-61.96 K213.19 M-357.52 K 226.58 M 自由现金流 -14.52 M-14.09 M-9.45 M-11.98 M-9.96 M -45.49 M

新闻

The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying

3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts - TipRanks.com

Piper Sandler因上市时间调整下调Immuneering目标价

Piper Sandler cuts Immuneering stock price target on launch timing

Oppenheimer维持Immuneering股票评级,看好管线进展

Oppenheimer reiterates Immuneering stock rating on pipeline progress

Immuneering’s (IMRX) chief business officer buys $24,990 in stock

Immuneering公司董事Schall购买价值10.1万美元股票

Immuneering首席人力官Neufeld购入价值$10,905的IMRX股票

Immuneering董事Feinberg购入价值8.69万美元股票

Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.55%